Objective: It has been reported that akathisia is a neurological side effect induced by antiemetic drugs and/or antipsychotics. Akathisia can occur in any area of the body, but respiratory akathisia is an unusual type of akathisia. Cases of respiratory akathisia in cancer patients taking antiemetic drugs have not previously been reported.

Methods: We report on a case of a cancer patient taking prochlorperazine as an antiemetic drug who experienced dyspnea accompanied by severe restlessness associated with respiration. By administration of biperiden, his restlessness in respiration and dyspnea promptly disappeared.

Results: This finding led us to conclude that this cancer patient was experiencing respiratory akathisia.

Significance Of Results: Respiratory akathisia is uncommon. It is important for cancer patients that dyspnea induced by disease progression be ruled out as a cause of the respiratory restlessness. It is necessary to consider the possibility of akathisia in patients that complain of vague anxiety, chest discomfort, or dyspnea following antipsychotic medication.

Download full-text PDF

Source
http://dx.doi.org/10.1017/S1478951508000114DOI Listing

Publication Analysis

Top Keywords

respiratory akathisia
16
cancer patient
12
akathisia
8
akathisia cancer
8
antiemetic drugs
8
cancer patients
8
cancer
5
respiratory
5
case respiratory
4
patient case
4

Similar Publications

Article Synopsis
  • * Researchers analyzed data from 376 patients over four years, finding similar rates of advanced airway management and no significant differences in intubation rates or mortality between the two medications.
  • * The conclusion indicates that both midazolam and ketamine have comparable safety profiles in terms of requiring emergency airway interventions for patients with acute behavioral disturbances.
View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on patients in the emergency department experiencing acute respiratory failure and explores how ketamine can help improve compliance with non-invasive mechanical ventilation (NIMV) in agitated patients.
  • Out of 81 patients analyzed, a significant number (56.8%) required intubation despite receiving ketamine, indicating ongoing challenges with NIMV compliance due to agitation.
  • The results suggest that while agitation negatively impacts NIMV compliance, using ketamine can reduce the need for invasive mechanical ventilation (IMV) in some cases.
View Article and Find Full Text PDF

Physical restraint and associated agitation.

Nurs Crit Care

September 2024

Department of Anesthesiology, Intensive Care and Pain Medicine, Meir Medical Center, Kfar Saba, Israel.

Background: Physical restraint of patients in intensive care units (ICUs) has an estimated prevalence of 50%. Many medical centres do not have specific protocols for physical restraint, and the decision of whether to physically restrain a patient is up to the nursing staff. Disadvantages of physical restraint include injuries, exacerbation of agitation and an increased risk of developing post-traumatic stress disorder (PTSD).

View Article and Find Full Text PDF

The synthetic cathinones MDPHP and MDPV: Comparison of the acute effects in mice, in silico ADMET profiles and clinical reports.

Neurotoxicology

July 2024

Department of Translational Medicine, Section of Legal Medicine and LTTA Centre, University of Ferrara, Ferrara, Italy; Department of Anti-Drug Policies, Collaborative Center for the Italian National Early Warning System, Presidency of the Council of Ministers, Ferrara, Italy. Electronic address:

The 3,4-methylenedioxy-alpha-pyrrolidinohexanophenone (MDPHP) is a synthetic cathinone closely related to 3,4-methylenedioxypyrovalerone (MDPV), one of the most common synthetic cathinones present in the "bath salts". MDPHP has recently gained attention due to increasing seizures and involvement in human intoxications which occurred in Europe and Italy in the last years, but currently there is a lack of information about its pharmaco-toxicological effects. With the aim at filling this gap, the present study is endeavoured to (i) evaluate the effects of acute administration of MDPHP (0.

View Article and Find Full Text PDF

Fixed dose ketamine for prehospital management of hyperactive delirium with severe agitation.

Am J Emerg Med

July 2024

Department of Emergency Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA.

Introduction: Patients exhibiting signs of hyperactive delirium with severe agitation (HDSA) may require sedating medications for stabilization and safe transport to the hospital. Determining the patient's weight and calculating the correct weight-based dose may be challenging in an emergency. A fixed dose ketamine protocol is an alternative to the traditional weight-based administration, which may also reduce dosing errors.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!